Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Dental Plaque Subcommittee adding five new ingredients/combos to May agenda.

This article was originally published in The Tan Sheet

Executive Summary

FDA DENTAL PLAQUE SUBCOMMITTEE ADDING FIVE INGREDIENTS/COMBOS TO MAY AGENDA on the first day of a three-day meeting set for May 27-29. The group is slated to discuss the safety and effectiveness of the combination of stannous pyrophosphate and zinc citrate, and the effectiveness of the combo of hydrogen peroxide, sodium lauryl sulfate, sodium citrate and zinc chloride. Additionally, the subcommittee is set to review the safety and effectiveness in dental products of hexetidine, soluble pyrophosphate, nonsaponifiable fraction of corn oil, bromchlorophene and chlorhexidine digluconate, FDA announced in the May 4 Federal Register.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088414

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel